Garvey Institute funds 12 projects to improve mental health care for adolescents and young adults

Garvey Institute for Brain Health Solutions | November 18, 2022

The UW Medicine Garvey Institute for Brain Health Solutions is awarding over $1 million to develop and test innovative approaches to caring for adolescents and young adults with mental health and addiction problems. The Innovation Grants will go to 12 UW faculty-led teams representing 7 UW schools and colleges, 12 departments and divisions and numerous UW- and community-based centers, institutes and organizations.


AI detects cognitive distortions in text messages

Psychology Today | October 20, 2022

A new study published in Psychiatric Services by members of the BRiTE Center shows how AI natural language processing can detect cognitive disorders in texts as effectively as human clinicians. Authors include Justin Tauscher, PhD, MS, Ayesha Chander, MRes, Trevor Cohen, MBChB, PhD, FACMI, and Dror Ben-Zeev, PhD. The work was supported by an innovation grant from the Garvey Institute for Brain Health Solutions.


AI equal to humans in text-message mental health trial

UW Medicine newsroom | October 11, 2022

Members of the BRiTE Center including Justin Tauscher, PhD, MS, Ayesha Chander, MRes, Trevor Cohen, MBChB, PhD, FACMI, and Dror Ben-Zeev, PhD, published findings in Psychiatric Services showing that algorithms are as good as trained human evaluators at identifying red-flag language in text messages from people with serious mental illness. The work was supported by an innovation grant from the Garvey Institute for Brain Health Solutions.


Root Cause

UW Tacoma News | August 4, 2022

UW Tacoma Assistant Professor Sunny Cheng's research focuses on mental health, particularly the impact of early intervention and screening. Dr. Cheng's research is funded in part by the Garvey Institute for Brain Health Solutions.


Final report: Does the microbiome play a role in adverse outcomes following mTBI and PTSD?

Department News | June 28, 2022

Through our Small Grants Program launched in 2020, and with support from the Garvey Institute for Brain Health Solutions, we allocated nearly $100,000 to a terrific set of diverse proposals from faculty, staff and trainees on a wide range of topics. Kathleen Pagulayan, PhD, Abigail Schindler, PhD, Rebecca Hendrickson, PhD, and Sean Gibbons, PhD, completed […]



The opioid epidemic: is pharma doing enough to develop treatments for the crisis?

Pharmaceutical Technology | May 30, 2022

Even with academic collaborations, private players are lagging behind public institutions in finding new treatments for opioid addiction. Marco Pravetoni, PhD, is currently working on developing a potential vaccine aimed at oxycodone, which is in Phase I trials, and aims to get vaccines targeting other drugs like fentanyl or heroin into the clinic in the coming years.